罗格列酮减轻大鼠自体颈静脉移植后内膜增生
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Rosiglitazone Alleviates Intimal Hyperplasia of Jugular Vein Graft after Autologous Transplantation in Rats
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的观察过氧化体增殖物激活型受体γ激动剂对大鼠移植静脉内膜增生的影响。方法建立大鼠颈静脉移植血管模型,16只大鼠被随机分为罗格列酮组和模型组,每组8只,饲养6周。罗格列酮组应用罗格列酮。6周后观察大鼠的体重变化、内膜增生程度,RT-PCR检测移植静脉过氧化体增殖物激活型受体γmRNA表达。结果术后饲养6周,模型组大鼠体重(521.6±22.3 g)较罗格列酮组(457.3±25.3 g)明显增加,差异有显著性(P><0.05)。与正常静脉相比,罗格列酮组(内膜厚度25.99±3.31μm)和模型组(内膜厚度35.28±5.76μm)的移植静脉出现了明显内膜增生,但罗格列酮组内膜增生比模型组明显减轻(P><0.05)。RT-PCR检测发现罗格列酮组移植静脉过氧化体增殖物激活型受体γmRNA表达显著高于模型组(1.12±0.28比0.68±0.20,P><0.05)。结论过氧化体增殖物激活型受体γ激动剂罗格列酮对大鼠移植静脉内膜增生有减轻作用。

    Abstract:

    Aim To observe the intimal hyperplasia of peroxisome proliferator activated receptor-γ(PPARγ) agonist rosiglitazone on vein graft. Methods Jugular veins graft model of rats were established.16 rats were divided into rosiglitazone group and model group randomly(8 in each group),rosiglitazone was used in rosiglitazone group.The weight of rats,hyperplasia endomembrane on light microscope,RT-PCR result of electrophoresis were observed after six weeks. Results The weight in model group(521.6±22.3 g) was increased compared with in rosiglitazone group(457.3±25.3 g,P><0.05).Hyperplasia endomembrane in rosiglitazone group was 25.99±3.31 μm and 35.28±5.76 μm in model group compared with normal vein.Expression of PPARγ mRNA in rosiglitazone group(1.12±0.28) was increased compared with model group(0.68±0.20,P><0.05). Conclusion PPARγ agonist rosiglitazone alleviates intimal hyperplasia of vein graft after autologous transplantation in rats.

    参考文献
    相似文献
    引证文献
引用本文

韩露, 修宗谊, 张继倬.罗格列酮减轻大鼠自体颈静脉移植后内膜增生[J].中国动脉硬化杂志,2010,18(8):633~635.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2010-06-11
  • 最后修改日期:2010-07-25
  • 录用日期:
  • 在线发布日期: